Connecting people, advancing clinical value
Connecting people, advancing clinical value
Overview From 1 to 30 September 2025 the Korean Ministry of Food and Drug Safety (MFDS) issued 62 approvals for investigational new drugs (INDs). Of these, 15 were for compounds developed domestically and 47 for products developed overseas, meaning about…
This report informs pharmaceutical and biotech professionals about MFDS approvals of clinical‑trial medical devices in September 2025. Seven approvals show how the landscape is shifting: digital therapeutic software, AI‑assisted image analysis, 3D‑printed ankle implants, automated insulin‑delivery software, an electronic thermometer,…